The rise of Viagra initially fueled a period of growth for pharma, but recent changes present a murky scenario for shareholders. Off-patent competitors are eating into earnings, and ongoing litigation add additional https://jaspertqpc791329.onesmablog.com/viagra-and-pharma-a-risky-investment-82562148